Dr. Sulaiman Al Habib Medical Services Group Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 3/6
Dr. Sulaiman Al Habib Medical Services Group verzeichnete einen durchschnittlichen jährlichen Gewinnzuwachs von 20.5%, während die Gewinne der Branche Healthcare jährlich um gewachsen und zwar um 18.7%. Die Umsätze verzeichneten einen durchschnittlichen jährlichen Gewinnzuwachs von gewachsen von 15.7%. Die Eigenkapitalrendite von Dr. Sulaiman Al Habib Medical Services Group beträgt 31.4% und die Nettomargen betragen 21.7%.
Wichtige Informationen
20.5%
Wachstumsrate der Gewinne
20.5%
EPS-Wachstumsrate
Healthcare Wachstum der Industrie | 12.3% |
Wachstumsrate der Einnahmen | 15.7% |
Eigenkapitalrendite | 31.4% |
Netto-Marge | 21.7% |
Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Recent updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27Aufschlüsselung der Einnahmen und Ausgaben
Wie Dr. Sulaiman Al Habib Medical Services Group Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
---|---|---|---|---|
30 Jun 24 | 10,024 | 2,176 | 1,257 | 0 |
31 Mar 24 | 9,723 | 2,108 | 1,206 | 0 |
31 Dec 23 | 9,508 | 2,046 | 1,158 | 0 |
30 Sep 23 | 9,276 | 1,962 | 1,134 | 0 |
30 Jun 23 | 8,885 | 1,838 | 1,089 | 0 |
31 Mar 23 | 8,627 | 1,750 | 1,069 | 0 |
31 Dec 22 | 8,311 | 1,651 | 1,032 | 0 |
30 Sep 22 | 8,025 | 1,593 | 971 | 0 |
30 Jun 22 | 7,809 | 1,521 | 932 | 0 |
31 Mar 22 | 7,547 | 1,448 | 887 | 0 |
31 Dec 21 | 7,250 | 1,377 | 850 | 0 |
30 Sep 21 | 6,974 | 1,311 | 822 | 0 |
30 Jun 21 | 6,761 | 1,261 | 851 | 0 |
31 Mar 21 | 6,213 | 1,128 | 796 | 0 |
31 Dec 20 | 5,862 | 1,055 | 738 | 0 |
30 Sep 20 | 5,575 | 1,008 | 696 | 0 |
30 Jun 20 | 5,178 | 907 | 618 | 0 |
31 Mar 20 | 5,132 | 883 | 632 | 0 |
31 Dec 19 | 5,016 | 870 | 647 | 0 |
30 Sep 19 | 4,816 | 825 | 619 | 0 |
30 Jun 19 | 4,735 | 835 | 601 | 0 |
31 Mar 19 | 4,646 | 819 | 569 | 0 |
31 Dec 18 | 4,588 | 801 | 551 | 0 |
31 Dec 17 | 4,687 | 658 | 904 | 0 |
31 Dec 16 | 4,868 | 1,010 | 959 | 0 |
31 Dec 15 | 5,123 | 1,329 | 859 | 0 |
Qualität der Erträge: 4013 einen hohen Anteil an unbarem Gewinn hat.
Wachsende Gewinnspanne: 4013Die aktuellen Gewinnspannen (21.7%) sind höher als im letzten Jahr (20.3%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 4013In den letzten 5 Jahren sind die Einnahmen von 20.5% pro Jahr erheblich gestiegen.
Beschleunigtes Wachstum: 4013Das Gewinnwachstum des Unternehmens im letzten Jahr (18.4%) liegt unter seinem 5-Jahres-Durchschnitt (20.5% pro Jahr).
Erträge im Vergleich zur Industrie: 4013 Das Gewinnwachstum im vergangenen Jahr (18.4%) übertraf nicht die Entwicklung der Branche Healthcare 42.3% .
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 4013Die Eigenkapitalrendite des Unternehmens (31.4%) wird als hoch angesehen.